Total Number of Shares and Voting Rights
On June 30, 2020
| Total number of outstanding shares |
Theoretical voting rights | Exercisable voting rights (minus treasury shares) |
| 78,317,810 | 78,317,810 | 78,117,816 |
Last updated on
Last updated on
Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.